Magnetic resonance outcome measures in multiple sclerosis trials-Reference-Cited by-同舟云学术

Magnetic resonance outcome measures in multiple sclerosis trials

Published:2014-06 Issue:3 Volume:27 Page:290-299
ISSN:1350-7540
Container-title:Current Opinion in Neurology
language:en
Short-container-title:

Author:

Filippi Massimo,Preziosa Paolo,Rocca Maria A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Reference74 articles.

1. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials.;Barkhof;J Neurol,1997

2. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.;Filippi;Ann Neurol,1998

3. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment Ann N;Goodin;eurol,2006

4. MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b.;Sormani;Neurology,2003

5. MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients.;Sormani;Neurology,2002

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of fingolimod on focal and diffuse damage in patients with relapsing–remitting multiple sclerosis – The “EVOLUTION” study;Journal of Neurology;2024-07-29

2. Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span;Ageing Research Reviews;2023-09

3. Prognostic value of single-subject grey matter networks in early multiple sclerosis;Brain;2023-08-29

4. “Brain age” predicts disability accumulation in multiple sclerosis;Annals of Clinical and Translational Neurology;2023-04-29

5. Functional MRI of Multiple Sclerosis;Functional Neuroradiology;2023